Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
geographic atrophy
MeSH D057092 - geographic atrophy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008268:
Macular degeneration
5 Companies
7 Drugs
$
Success rate
D057092:
Geographic atrophy
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Astellas Pharma
Avacincaptad pegol
Izervay
2025-02-14
2023-08-04
Clinical Trials
Historical Success Rate
Phase 1
100
%
4/4
Phase 2
42
%
5/12
Phase 3
0
%
0/5
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Astellas Pharma
Avacincaptad pegol sodium
,
Avacincaptad pegol
,
Polyglycolic acid
,
Co-trimoxazole
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use